Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.17 CAD | 0.00% | 0.00% | -8.11% |
Mar. 15 | NeuPath Health Narrows Q4 Loss, Revenue Rises | MT |
Mar. 15 | NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 156
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Walewicz
CEO | Chief Executive Officer | 55 | 20-06-24 |
Danish Baig
DFI | Director of Finance/CFO | - | 23-04-30 |
Jeff Zygouras
DFI | Director of Finance/CFO | - | 18-12-31 |
Peter Blecher
CTO | Chief Tech/Sci/R&D Officer | - | - |
Bjorn Thies
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Walewicz
CEO | Chief Executive Officer | 55 | 20-06-24 |
Daniel Chicoine
CHM | Chairman | 70 | 20-06-24 |
Sasha Cucuz
BRD | Director/Board Member | 46 | 20-06-24 |
Jolyon Burton
BRD | Director/Board Member | 48 | 17-05-09 |
Daniel Legault
BRD | Director/Board Member | 66 | 19-04-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 56,293,000 | 55,719,477 ( 98.98 %) | 0 | 98.98 % |
Company contact information
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.11% | 7.01M | |
-29.41% | 70.3B | |
+2.04% | 27.46B | |
-6.54% | 17.8B | |
+2.32% | 17.46B | |
+2.13% | 15.46B | |
+6.71% | 13.49B | |
+10.80% | 13.06B | |
+72.40% | 12.96B | |
+73.99% | 12.56B |
- Stock Market
- Equities
- NPTH Stock
- Company NeuPath Health Inc.